-
Mashup Score: 7
Black Medicare beneficiaries who underwent elective cancer surgery had higher rates of mortality than their white counterparts, irrespective of neighborhood deprivation or dual eligibility status, according to study results.The findings, presented at Society of Surgical Oncology International 2022 Conference on Surgical Cancer Care, also showed a more pronounced effect of race among those with
Source: www.healio.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
NEW Perspective from Haejin In, MD of @RutgersCancer & @RWJBarnabas examines study presented at #SSO2020 showing higher mortality rates among Black Medicare recipients who undergo elective cancer READ more here: https://t.co/BNnwZcGvz1 #oncology @SocSurgOnc @HInMD https://t.co/XmMbzw3cqy
-
-
Mashup Score: 0
Women with ductal carcinoma in situ and elevated commercial DCISion scores (DS) had a significantly higher risk for ipsilateral breast events and a greater relative benefit from radiation therapy than women with lower scores.
Source: www.generalsurgerynews.comCategories: Latest Headlines, SurgeryTweet-
DCIS biological risk signature predicts recurrence, radiation benefit. https://t.co/rIMfVcRPfQ @TheRMH @SocSurgOnc #SSO2020
-
-
Mashup Score: 0
Women with ductal carcinoma in situ and elevated commercial DCISion scores had a significantly higher risk for ipsilateral breast events and a greater relative benefit from radiation therapy than women with lower scores.
Source: www.clinicaloncology.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
DCIS biological risk signature predicts recurrence, radiation benefit. https://t.co/hWoNgs81UM @TheRMH @SocSurgOnc #SSO2020
-
-
Mashup Score: 0
Women with ductal carcinoma in situ and elevated commercial DCISion scores had a significantly higher risk for ipsilateral breast events and a greater relative benefit from radiation therapy than women with lower scores.
Source: www.clinicaloncology.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
DCIS biological risk signature predicts recurrence, radiation benefit. https://t.co/hWoNgs81UM @TheRMH @SocSurgOnc #SSO2020
-
-
Mashup Score: 0
Women with ductal carcinoma in situ and elevated commercial DCISion scores had a significantly higher risk for ipsilateral breast events and a greater relative benefit from radiation therapy than women with lower scores.
Source: www.clinicaloncology.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
DCIS biological risk signature predicts recurrence, radiation benefit. https://t.co/hWoNgs81UM @TheRMH @SocSurgOnc #SSO2020
-
-
Mashup Score: 0
Women with ductal carcinoma in situ and elevated commercial DCISion scores (DS) had a significantly higher risk for ipsilateral breast events and a greater relative benefit from radiation therapy than women with lower scores.
Source: www.generalsurgerynews.comCategories: Latest Headlines, SurgeryTweet-
DCIS biological risk signature predicts recurrence, radiation benefit. https://t.co/rIMfVcRPfQ @TheRMH @SocSurgOnc #SSO2020
-
-
Mashup Score: 0
Women with ductal carcinoma in situ and elevated commercial DCISion scores had a significantly higher risk for ipsilateral breast events and a greater relative benefit from radiation therapy than women with lower scores.
Source: www.clinicaloncology.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
DCIS biological risk signature predicts recurrence, radiation benefit. https://t.co/hWoNgs81UM @TheRMH @SocSurgOnc #SSO2020
-
-
Mashup Score: 2SSO 2020 Virtual Meeting - 4 year(s) ago
Skip Navigation…
Source: experted.surgonc.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
The #SSO2020 Virtual Meeting is available now in ExpertEd. Watch the James Ewing Lecture given by @ppisters, the SSO Presidential Address, "Surgical Oncology Moonshot," delivered by @DavidBartlettMD and more. Find all of the practice-changing research at https://t.co/OLFArFUJKy. https://t.co/rVwjMCxxwB
-
-
Mashup Score: 0SSO 2020 International Conference on Surgical Cancer Care - 4 year(s) ago
Join your colleagues for a live, virtual event the evenings of August 17th and 18th. The SSO 2020 Scientific Program Committee (SPC) is planning a virtual meeting with an abbreviated program schedule that will include general sessions, featured lecturers and various disease-site sessions.
Categories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Congratulations to Giacomo Montagna, MD, MPH & Oriana A. Petruolo, MD, @sloan_kettering on the selection of their work as the #SSO2020 Resident/Fellow Essay Contest winner. Find Dr. Montagna's & Dr. Petruolo's poster & all virtual meeting content at https://t.co/RsmX7fZ2AJ. https://t.co/zLHKkabBm7
-
-
Mashup Score: 0SSO 2020 International Conference on Surgical Cancer Care - 4 year(s) ago
Join your colleagues for a live, virtual event the evenings of August 17th and 18th. The SSO 2020 Scientific Program Committee (SPC) is planning a virtual meeting with an abbreviated program schedule that will include general sessions, featured lecturers and various disease-site sessions.
Categories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Congratulations to Thomas O'Keefe, MD, on the selection of his work as the #SSO2020 Best Clinical Research Poster. Find all of the great content from the virtual meeting, including Dr. O'Keefe's poster, at https://t.co/RsmX7fZ2AJ. https://t.co/jFbVpxaxeL
-
NEW Perspective from Haejin In, MD of @RutgersCancer & @RWJBarnabas examines study presented at #SSO2020 showing higher mortality rates among Black Medicare recipients who undergo elective cancer READ more here: https://t.co/BvGPZMWkw7 #oncology @SocSurgOnc @HInMD https://t.co/JIV94wjS07